Please assess the completion status of the following clinical trial:

Trial Title: Use of an Endoluminal-suturing Device for Endoscopic Gastric Reduction As an Aid for Class I Obesity, or Class II Obesity Without Comorbidity

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years ≤ age ≤ 65 years~* Class I obesity (30 \<BMI \<35 kg / m²) or Class II without comorbidity (35 \<BMI \<40 kg / m²)~Exclusion Criteria:~* Achalasia or other disturbance of motility of the esophagus;~* severe esophagitis;~* Peptic ulcer disease;\* uncontrolled diabetes~* Weight loss\> 5% of the total weight over the last 6 months;~* Gastrointestinal stenosis or obstruction;~* Pregnancy, breastfeeding, or desire for pregnancy in the next 18 months;~* Previous bariatric surgery, balloon or other endoscopic therapy of obesity;~* Gastric surgery scheduled within 60 days of surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Vertical gastric plication (Type: EXPERIMENTAL): Vertical gastric plication ( without cutting gastric wall) is a novel surgical approach for reducing the stomach capacity. A transoral or endoluminal approach (i.e. a procedure that requires no incision, because access is granted through the mouth) offers some potential additional benefit to the patient, because the procedures continue to become more and more minimally invasive

Based on this trial design, predict the completion outcome and termination type (if applicable).